ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
維升藥業-B
33.020
-1.440
-4.18%
手動刷新
成交量:
4.59萬
成交額:
155.43萬
市值:
37.64億
市盈率:
-16.97
高:
36.700
開:
36.700
低:
32.980
收:
34.460
52周最高:
69.150
52周最低:
32.800
股本:
1.14億
香港流通股本:
1.14億
量比:
1.56
換手率:
0.04%
股息:
- -
股息率:
- -
每股收益(LYR):
-1.946
淨資產收益率:
-57.66%
總資產收益率:
-29.52%
市淨率:
4.02
市盈率(LYR):
-16.97
市銷率:
4086.24
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
維升藥業尾盤漲超4%公司在進博會達成多項合作攜兩款全球創新藥物登場亮相
动脉网
·
昨天
維升藥業-B盤中異動 早盤股價大跌5.02%
市场透视
·
11/11
打破「進口依賴」,中國醫藥企業創新速度提升
中国新闻网
·
11/11
直通進博會 | 進博首秀即雙簽約!維升藥業攜手東富龍、臨港新片區共築生物醫藥生態
新华财经
·
11/07
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02561"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02561","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02561\",,,,,undefined,":{"symbol":"02561","market":"HK","secType":"STK","nameCN":"維升藥業-B","latestPrice":33.02,"timestamp":1763107689780,"preClose":34.46,"halted":0,"volume":45900,"delay":0,"floatShares":113999999,"shares":113999999,"eps":-1.946273,"marketStatus":"已收盤","change":-1.44,"latestTime":"11-14 16:08:09","open":36.7,"high":36.7,"low":32.98,"amount":1554340,"amplitude":0.107951,"askPrice":33.36,"askSize":100,"bidPrice":33,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-2.238552,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1763343000000},"marketStatusCode":5,"adr":0,"listingDate":1742486400000,"exchange":"SEHK","adjPreClose":34.46,"openAndCloseTimeList":[[1763083800000,1763092800000],[1763096400000,1763107200000]],"volumeRatio":1.558045,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02561\",,,,,undefined,":{"symbol":"02561","floatShares":113999999,"roa":"-29.52%","roe":"-57.66%","lyrEps":-1.946273,"volumeRatio":1.558045,"shares":113999999,"dividePrice":0,"high":36.7,"amplitude":0.107951,"preClose":34.46,"low":32.98,"week52Low":32.8,"pbRate":"4.02","psRate":"4086.24","week52High":69.15,"institutionHeld":0,"latestPrice":33.02,"committee":0.333333,"eps":-1.946273,"divideRate":0,"volume":45900,"delay":0,"ttmEps":-2.238552,"open":36.7,"prevYearClose":68.8,"prevWeekClose":36.46,"prevMonthClose":38.02,"prevQuarterClose":42.5,"fiveDayClose":36.46,"twentyDayClose":40.4,"sixtyDayClose":47.02},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02561\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02561\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02561\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":2,"updateTime":1746288000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02561\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02561","date":"2025-11-13","current":-14.750607,"percent":0.987013,"low":-30.760225,"twenty":-27.764882,"median":-26.313071,"eighty":-18.919941,"high":-14.784203,"avg":-24.499309,"sd":4.145138,"marketCap":3619036203},"quantilePoints":[{"date":"2025-04-03","current":-21.475965,"twenty":-22.637245,"median":-22.569747,"eighty":-22.098421,"marketCap":5724824916},{"date":"2025-04-11","current":-18.134639,"twenty":-22.558476,"median":-18.349759,"eighty":-18.045823,"marketCap":4802017317},{"date":"2025-04-17","current":-25.787715,"twenty":-25.955056,"median":-22.513392,"eighty":-18.141011,"marketCap":4682394110},{"date":"2025-04-25","current":-29.965674,"twenty":-27.695216,"median":-22.653961,"eighty":-18.190408,"marketCap":5445704099},{"date":"2025-05-02","current":-28.244363,"twenty":-27.861811,"median":-26.066617,"eighty":-18.349759,"marketCap":5143797909},{"date":"2025-05-09","current":-27.581562,"twenty":-28.248468,"median":-27.028836,"eighty":-20.850724,"marketCap":5058352761},{"date":"2025-05-16","current":-27.481285,"twenty":-28.307048,"median":-27.470681,"eighty":-22.305907,"marketCap":5081138134},{"date":"2025-05-23","current":-29.180898,"twenty":-28.483617,"median":-27.481285,"eighty":-22.603559,"marketCap":5411526040},{"date":"2025-05-30","current":-27.585218,"twenty":-28.483617,"median":-27.495492,"eighty":-22.648389,"marketCap":5138101566},{"date":"2025-06-06","current":-26.147365,"twenty":-28.307048,"median":-27.481285,"eighty":-24.987287,"marketCap":5212154028},{"date":"2025-06-13","current":-28.707887,"twenty":-28.307048,"median":-27.486097,"eighty":-25.744296,"marketCap":5724824916},{"date":"2025-06-20","current":-27.87701,"twenty":-28.483617,"median":-27.500076,"eighty":-26.010837,"marketCap":5548238276},{"date":"2025-06-27","current":-26.600431,"twenty":-28.46744,"median":-27.491566,"eighty":-26.131215,"marketCap":5308991862},{"date":"2025-07-04","current":-25.999842,"twenty":-28.345085,"median":-27.470681,"eighty":-26.039907,"marketCap":5189368655},{"date":"2025-07-11","current":-25.483255,"twenty":-28.252573,"median":-27.442177,"eighty":-25.700877,"marketCap":5081138134},{"date":"2025-07-18","current":-27.275886,"twenty":-28.168194,"median":-27.211053,"eighty":-25.700877,"marketCap":5434311412},{"date":"2025-07-25","current":-27.917728,"twenty":-28.10544,"median":-27.177054,"eighty":-25.808828,"marketCap":5582416336},{"date":"2025-08-01","current":-26.858726,"twenty":-28.252573,"median":-27.236899,"eighty":-25.835301,"marketCap":5337473578},{"date":"2025-08-08","current":-26.45431,"twenty":-28.168194,"median":-27.174901,"eighty":-25.937332,"marketCap":5270256728},{"date":"2025-08-15","current":-27.513449,"twenty":-28.142473,"median":-27.236899,"eighty":-26.012565,"marketCap":5473046546},{"date":"2025-08-22","current":-26.703746,"twenty":-28.118557,"median":-27.177054,"eighty":-26.021282,"marketCap":5295320638},{"date":"2025-08-29","current":-26.119434,"twenty":-28.10544,"median":-27.144467,"eighty":-26.021282,"marketCap":5204179147},{"date":"2025-09-05","current":-23.791598,"twenty":-28.093765,"median":-27.114576,"eighty":-25.835301,"marketCap":4735670561},{"date":"2025-09-12","current":-23.381705,"twenty":-28.083375,"median":-27.05699,"eighty":-25.694259,"marketCap":4662460107},{"date":"2025-09-19","current":-23.051901,"twenty":-28.060478,"median":-27.021811,"eighty":-25.478949,"marketCap":4593433106},{"date":"2025-09-26","current":-21.933119,"twenty":-28.003961,"median":-26.881441,"eighty":-23.835003,"marketCap":4359159651},{"date":"2025-10-03","current":-19.179371,"twenty":-27.951558,"median":-26.814509,"eighty":-23.612343,"marketCap":4545323379},{"date":"2025-10-10","current":-18.42629,"twenty":-27.909584,"median":-26.722604,"eighty":-23.450061,"marketCap":4360487033},{"date":"2025-10-17","current":-18.280755,"twenty":-27.87397,"median":-26.671617,"eighty":-23.093007,"marketCap":4322679342},{"date":"2025-10-24","current":-17.856771,"twenty":-27.855424,"median":-26.557884,"eighty":-22.535934,"marketCap":4223959260},{"date":"2025-10-31","current":-16.854881,"twenty":-27.829876,"median":-26.452186,"eighty":-21.933119,"marketCap":3992912259},{"date":"2025-11-07","current":-16.17341,"twenty":-27.822718,"median":-26.363703,"eighty":-19.806882,"marketCap":3829078931},{"date":"2025-11-13","current":-15.24303,"twenty":-27.764882,"median":-26.313071,"eighty":-18.919941,"marketCap":3619036203}],"updateTime":1763125174133},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02561\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2583915625","title":"維升藥業尾盤漲超4%公司在進博會達成多項合作攜兩款全球創新藥物登場亮相","url":"https://stock-news.laohu8.com/highlight/detail?id=2583915625","media":"动脉网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583915625?lang=zh_tw&edition=fundamental","pubTime":"2025-11-13 15:15","pubTimestamp":1763018100,"startTime":"0","endTime":"0","summary":"港股维升药业-B(02561)尾盘涨超4%,截至发稿涨4.05%,报34.98港元,成交额96.64万港元。11月6日第八届进博会期间,维升药业达成多项合作,与东富龙达成双腔冻干制剂技术战略合作,还与临港新片区管委会等签署产业协同协议,推动“全球创新、中国加速”战略进一步落地。此外,维升药业今年首次以参展商身份亮相进博会,携两款全球创新药物登场,包括全球首个且唯一用于治疗成人慢性甲状旁腺功能减退症(HP)的激素替代治疗药物帕罗培特立帕肽,以及致力于成为“潜在同类最佳”的隆培生长激素。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511131526239501affd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511131526239501affd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02561","BK1574","BK1161","06978"],"gpt_icon":0},{"id":"2582312262","title":"維升藥業-B盤中異動 早盤股價大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582312262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582312262?lang=zh_tw&edition=fundamental","pubTime":"2025-11-11 10:27","pubTimestamp":1762828061,"startTime":"0","endTime":"0","summary":"2025年11月11日早盘10时27分,维升药业-B股票出现异动,股价急速下挫5.02%。资金方面,该股资金流入18.1122万港元,流出16.5002万港元。维升药业-B股票所在的生物技术行业中,整体跌幅为0.46%。其相关个股中,旺山旺水-B、嘉和生物-B、华康生物医学涨幅较大,振幅较大的相关个股有旺山旺水-B、嘉和生物-B、维升药业-B,振幅分别为14.47%、12.67%、7.64%。维升药业-B公司简介:维升药业是一家主要从事开发并商业化颠覆式内分泌疗法的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111102741a49898d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111102741a49898d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02561","BK1161"],"gpt_icon":0},{"id":"2582804221","title":"打破「進口依賴」,中國醫藥企業創新速度提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2582804221","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582804221?lang=zh_tw&edition=fundamental","pubTime":"2025-11-11 00:05","pubTimestamp":1762790700,"startTime":"0","endTime":"0","summary":"在这场全球经贸盛会上,中国医药健康产业呈现出前所未有的创新活力:从AI赋能的智慧医疗,到全球新药加速落地,一系列变革正在推动行业从“追赶者”走向“共创者”。在肿瘤治疗领域,复星医药同样带来多项创新突破。同时,复星凯瑞的第二款CAR-T产品也已提交上市申请。以“全球重要采购方”的角色,向世界传递出中国对创新药械的稳定需求和扩大采购的明确意愿。正如复星国际董事长郭广昌所言,中国的医药创新越来越获得全世界的认可。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111100081394fbb7d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111100081394fbb7d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02561","02196","BK1161"],"gpt_icon":0},{"id":"2581001197","title":"直通進博會 | 進博首秀即雙簽約!維升藥業攜手東富龍、臨港新片區共築生物醫藥生態","url":"https://stock-news.laohu8.com/highlight/detail?id=2581001197","media":"新华财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581001197?lang=zh_tw&edition=fundamental","pubTime":"2025-11-07 11:19","pubTimestamp":1762485572,"startTime":"0","endTime":"0","summary":"深耕临港产业生态 夯实本土发展根基值得关注的是,维升药业是临港新片区洋山特殊综合保税区重点引进的一家专注于内分泌相关治疗领域的创新型生物医药企业,治疗范围涵盖成人内分泌、儿童内分泌及内分泌罕见病。此次维升药业与临港新片区管委会、临港集团物贸平台的签约,则进一步深化了公司与临港的产业协同关系。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110711195997598c36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110711195997598c36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02561","BK1161"],"gpt_icon":0}],"pageSize":4,"totalPage":12,"pageCount":1,"totalSize":46,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02561\",params:#limit:6,delay:false,,,undefined,":[]}}